Merck Animal Health

21 articles about Merck Animal Health

• Merck Animal Health to Acquire Elanco’s Aqua Business

  2/5/2024

  Merck Animal Health announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species.

• Elanco Announces Sale of Aqua Business for $1.3 Billion

  2/5/2024

  Elanco Animal Health Incorporated announced it has entered into an agreement to sell its aqua business to Merck Animal Health for approximately $1.3 billion in cash, which represents approximately 7.4x the estimated 2023 revenue of the Elanco aqua business.

• ByoPlanet and Merck Animal Health Announce Partnership with USEF

  5/23/2023

  ByoPlanet, a wholly owned subsidiary of Plandai Biotechnology, Inc. and Merck Animal Health are proud to announce a groundbreaking partnership with The United States Equestrian Federation to advance animal health through innovative products and technologies.

• Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health

  5/19/2023

  ByoPlanet is excited to announce the establishment of a comprehensive one-year distribution agreement with Merck Animal Health, a global leader in animal health solutions and a division of Merck & Co.

• Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs

  1/26/2023

  Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Food and Drug Administration’s approval of an expanded indication for BRAVECTO® Chews for Dogs.

• Merck Animal Health to Acquire Vence

  9/22/2022

  Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced that it has signed a definitive agreement under which Merck Animal Health will acquire Vence from its founders and shareholders.

• Merck Animal Health's Third Veterinarian Wellbeing Study Reveals Increased Health Challenges and Psychological Distress Among Veterinarians

  1/18/2022

  Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA, released findings of its comprehensive study conducted in collaboration with the American Veterinary Medical Association examining the wellbeing and mental health of U.S. veterinarians.

• Merck Animal Health Completes Acquisition of Poultry Sense Limited

  2/25/2021

  Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA, announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders.

• Merck Animal Health Survey Reveals First-Time Dog Owners Need Support

  11/23/2020

  Merck Animal Health, known as MSD Animal Health outside the US and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA, announced a new survey about first-time dog owners and whether or not they were prepared for pet parenthood.

• Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day

  9/28/2020

  In recognition of World Rabies Day on September 28, Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA, announced the launch of a global campaign to raise awareness among veterinarians, dog owners and volunteers who are committed to eliminate rabies through ongoing dog vaccination efforts.

• Merck Animal Health Completes Acquisition of IdentiGEN

  8/5/2020

  Strategic Transaction Enhances Farm-to-Table Animal Traceability Solutions for Livestock and Aquaculture

• Merck Animal Health Receives U.S. FDA Approval of BRAVECTO® (fluralaner) Monthly Chews

  7/9/2020

  Portfolio Expansion Ensures Dogs and Puppies 8 Weeks of Age and Older Receive Early, Broad-Spectrum Protection Against Fleas and Ticks

• Merck Animal Health to Acquire U.S. Rights to SENTINEL® Brand of Combination Parasiticides for Companion Animals

  5/13/2020

  Further Solidifies Merck Animal Health’s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection

• Elanco Signs Agreement with Merck Animal Health to Divest Worldwide Rights for Vecoxan®

  2/19/2020

  Elanco Animal Health Incorporated announced it signed an agreement with Merck Animal Health to divest worldwide rights for Vecoxan® for $55 million in an all-cash deal.

• Merck Animal Health Completes Acquisition of Vaki to Further Broaden Its Leadership Position in Aquaculture to Advance Fish Health and Welfare

  12/17/2019

  Strategic Transaction Benefits and Improves Aquaculture Health and Performance

• Merck Animal Health Introduces BRAVECTO® Cares to Show Support for the Health of Service Dogs

  5/21/2019

  Sponsorship of NEADS World Class Service Dogs Underscores the Importance of Keeping Pets Protected from Fleas and Ticks

• Merck Animal Health Announces Increase in Funding for Veterinary Student Scholarship Program

  11/14/2017

  Merck Animal Health has announced an increase of $115,000 in funding for its Veterinary Student Scholarship Program.

• Merck Animal Health Introduces Care & Control of Pet Diabetes to Help Pet Owners Deal With the Disease

  11/7/2017

  Merck Animal Health has launched Care & Control of Pet Diabetes Featuring Sugar & Spike, a global educational program to provide pet owners with the tools they need to help manage their pets’ diabetes.

• Merck Animal Health Extends Commitment To Fighting Rabies In The World’s Most At-Risk Regions

  9/28/2017

• Aurinia Completes Licensing Deal With Merck Animal Health For Its Nanomicellar Formulation Of Voclosporin For The Treatment Of Canine Dry Eye Syndrome

  4/18/2017